SurpassMD vs Fridays: Flat GLP-1 Pricing vs Coaching Compared
SurpassMD leads on flat, transparent pricing: compounded semaglutide as low as $114/month and compounded tirzepatide as low as $177/month — the same price at every dose, so your bill never climbs as you titrate up. It ships cold within 48 hours, offers a needle-free oral semaglutide option, and includes nutrition guidance. Fridays sells a program: semaglutide from $150/month (12-month prepaid) wrapped in deeper 1:1 nutritionist coaching, clinician consultations, and insurance support for brand-name drugs — though it does not offer compounded tirzepatide. The right choice depends on whether you want the lowest flat price or a more hands-on coached program around your medication.
Side-by-Side Comparison (July 2026)
| Feature | SurpassMD | Fridays |
|---|---|---|
| Compounded semaglutide | As low as $114/mo | $249/mo rolling |
| Semaglutide (12-mo prepay) | Flat rate, no prepay needed | $150/mo ($1,800 upfront) |
| Compounded tirzepatide | As low as $177/mo | Not offered |
| Dose escalation | Flat — no increase with dose | Not applicable (single-dose pricing) |
| Brand-name path | Not offered | Ozempic $1,498, Zepbound $1,828 + insurance help |
| Oral semaglutide | Available (needle-free) | Available |
| Nutrition & coaching | Nutrition guidance included | Deeper 1:1 nutritionist + clinician consults |
| Insurance support | Cash-pay only | Yes, for brand medications |
| Shipping | Cold, within 48 hours | 3-7 business days |
| Billing | HSA/FSA, Klarna, cancel anytime | Monthly or 3/6/12-mo prepay |
| Coverage | 50 states + DC | Most states |
Program vs Medication: What You Are Actually Buying
The gap between SurpassMD's flat $114/month and Fridays' $249/month rolling rate largely funds Fridays' deeper coaching layer and insurance operations. Both platforms include nutrition guidance; the difference is depth — Fridays adds more hands-on 1:1 nutritionist coaching and clinician consultations. Whether that is worth it depends on usage: patients who engage with intensive coaching show meaningfully better weight loss adherence in program-style studies, but self-directed patients who skip check-ins pay for a service they never use. SurpassMD's pricing stays flat as you titrate up, so the medication cost never climbs with your dose — see our guide on GLP-1 tapering.
The insurance angle is underrated: if Fridays gets your Wegovy or Zepbound covered at a $25-100 copay, that outcome beats every compounded price in the market, including SurpassMD's. Check whether your plan covers GLP-1s before choosing either platform.
Verdict: Which Should You Choose?
Choose SurpassMD for the lowest flat price with no dose-based increases, compounded tirzepatide (which Fridays does not offer), a needle-free oral semaglutide option, fast 48-hour shipping, and included nutrition guidance. Choose Fridays for deeper 1:1 coaching accountability, a realistic shot at insurance-covered brand medication, or the $150/month semaglutide rate if you can prepay a year with confidence. First-time users uncertain about tolerance should not prepay anywhere.
Full reviews: SurpassMD review and Fridays review. See also best GLP-1 telehealth providers and the full price comparison.
Frequently Asked Questions
SurpassMD is priced as low as $114/month, flat across all doses — the price does not rise as you titrate up, and the "as low as" rate reflects the longest-subscription option with no prepayment lump sum required. Fridays charges $249/month on a rolling plan; its committed plans work out to about $199/month (3-month, $596), $175/month (6-month, $1,050), and $150/month (12-month, $1,800 upfront). Fridays' 12-month prepay is the cheapest per-month semaglutide rate if you can commit a year in advance; SurpassMD is the cheapest no-commitment option.
Two things: deeper 1:1 nutritionist coaching with clinician consultations bundled into every plan, and insurance-navigation support for brand-name medications like Ozempic and Zepbound, including prior-authorization help. SurpassMD also includes nutrition guidance, but Fridays' coaching is more hands-on. If your insurance might cover a brand-name GLP-1, Fridays' paperwork support alone can be worth more than any compounded price difference.
SurpassMD offers compounded tirzepatide as low as $177/month, flat across all doses. Fridays does not offer compounded tirzepatide — its tirzepatide path is brand-name Zepbound at $1,828 per 28-day cycle before insurance. Patients set on compounded tirzepatide should look at SurpassMD, which offers it at a flat price regardless of dose.
Prepay only if you already tolerate semaglutide. Fridays' $150/month rate requires $1,800 upfront on a medication a meaningful share of patients discontinue early for side effects. SurpassMD needs no prepayment to reach its flat $114/month rate and you can cancel anytime. A lower-risk sequence: confirm tolerance for 2-3 months, then decide whether Fridays' 12-month commitment is worth it. Check Fridays' refund terms for unused months before prepaying.
SurpassMD ships cold within 48 hours of approval; Fridays quotes 3-7 business days. Both run online intake with licensed provider review. Fridays adds scheduled clinician consultations and deeper coaching check-ins; SurpassMD keeps the process lean while still including nutrition guidance. Both accept HSA/FSA for compounded plans.
Choose SurpassMD if you want the lowest flat price with no dose-based increases, fast 48-hour shipping, a needle-free oral semaglutide option, nutrition guidance, or compounded tirzepatide (which Fridays does not offer). Choose Fridays if you want deeper 1:1 accountability coaching, think your insurance might cover brand-name medication, or are ready to prepay 12 months for the $150/month semaglutide rate. Be honest about which patient you are.
This page is informational and is not medical advice. SurpassMD is operated by Life Vitality LLC, which also owns Peptide Dossier. Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. Prescriptions are never guaranteed. Pricing verified July 2026 and subject to change.